In this review, we will briefly present and describe the NADPH oxidases relevant to CNS pathophysiology and explore our current understanding of the role played by these enzymes in blood–brain barrier (BBB) disruption induced by ischemic stroke. The gene discussed is FMO5; the disease is ischemic stroke.